Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 126

1.

Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and Enzalutamide.

Wallis CJD, Chandrasekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z.

Eur Urol Oncol. 2018 Aug;1(3):238-241. doi: 10.1016/j.euo.2018.04.004. Epub 2018 May 15.

PMID:
31102627
2.

"Reverse Stage Migration": What Can Population-based Data Tell Us About Trends in Prostate Cancer Presentation?

Wallis CJD, Klaassen Z.

Eur Urol Oncol. 2018 Sep;1(4):321-322. doi: 10.1016/j.euo.2018.06.008. Epub 2018 Jul 6. No abstract available.

PMID:
31100254
3.

Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?

Wettstein MS, Rooprai JK, Pazhepurackel C, Wallis CJD, Klaassen Z, Uleryk EM, Hermanns T, Fleshner NE, Zlotta AR, Kulkarni GS.

PLoS One. 2019 Apr 29;14(4):e0216255. doi: 10.1371/journal.pone.0216255. eCollection 2019.

4.

Cancer diagnosis and risk of suicide after accounting for prediagnosis psychiatric care: A matched-cohort study of patients with incident solid-organ malignancies.

Klaassen Z, Wallis CJD, Chandrasekar T, Goldberg H, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS.

Cancer. 2019 Apr 25. doi: 10.1002/cncr.32146. [Epub ahead of print]

PMID:
31021430
5.

Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer.

Williams SB, Hudgins HK, Ray-Zack MD, Chamie K, Smaldone MC, Boorjian SA, Daneshmand S, Black PC, Kamat AM, Goebell PJ, Seiler R, Schmitz-Drager B, Nawroth R, Baillargeon J, Klaassen Z, Kulkarni GS, Kim SP, Lee EK, Holzbeierlein JM, Hollenbeck BK, Gore JL.

Eur Urol Oncol. 2019 Mar;2(2):119-125. doi: 10.1016/j.euo.2018.07.006. Epub 2018 Aug 14.

PMID:
31017086
6.

Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.

Goldberg H, Ramiz AH, Glicksman R, Salgado NS, Chandrasekar T, Klaassen Z, Wallis CJD, Hosni A, Moraes FY, Ghai S, Kulkarni GS, Hamilton RJ, Perlis N, Toi A, Chung P, Evans A, van der Kwast T, Finelli A, Fleshner N, Berlin A.

Eur Urol Oncol. 2019 Feb;2(1):88-96. doi: 10.1016/j.euo.2018.05.003. Epub 2018 May 27.

PMID:
30929849
7.

Mental Illness and Bladder Cancer Patients: The Time for Assertive Intervention Is Now.

Klaassen Z, Lokeshwar SD, Lowery-Allison A, Wallis CJD.

Eur Urol Focus. 2019 Mar 9. pii: S2405-4569(19)30075-6. doi: 10.1016/j.euf.2019.02.022. [Epub ahead of print] No abstract available.

PMID:
30862421
8.

Perioperative venous thromboembolism prophylaxis in prostate cancer surgery.

Klaassen Z, Wallis CJD, Lavallée LT, Violette PD.

World J Urol. 2019 Mar 6. doi: 10.1007/s00345-019-02705-x. [Epub ahead of print]

PMID:
30840115
9.

The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies.

Klaassen Z, Wallis CJD, Goldberg H, Chandrasekar T, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS.

Br J Cancer. 2019 Apr;120(8):840-847. doi: 10.1038/s41416-019-0390-0. Epub 2019 Mar 6.

PMID:
30837680
10.

Re: Prostate Cancer-specific Mortality Across Gleason Scores in Black vs Nonblack Men.

Wallis CJD, Klotz L, Klaassen Z.

Eur Urol. 2019 Jun;75(6):1036-1037. doi: 10.1016/j.eururo.2019.02.019. Epub 2019 Feb 26. No abstract available.

PMID:
30819526
11.

Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients.

Sayyid RK, Alibhai SMH, Sutradhar R, Eberg M, Fung K, Klaassen Z, Goldberg H, Perlis N, Madi R, Terris MK, Urbach DR, Fleshner NE.

Urol Oncol. 2019 May;37(5):298.e19-298.e27. doi: 10.1016/j.urolonc.2019.01.030. Epub 2019 Feb 13.

PMID:
30770299
12.

Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?

Goldberg H, Cheung DC, Chandrasekar T, Klaassen Z, Wallis CJD, Kulkarni GS, Sayyid R, Evans A, Masoomian M, Bapat B, Van Der Kwast T, Hamilton RJ, Zlotta A, Fleshner N.

Can Urol Assoc J. 2019 Jan 21. doi: 10.5489/cuaj.5595. [Epub ahead of print]

PMID:
30763230
13.

Decreasing incidence of venous thromboembolic events after radical cystectomy: are we finally improving?

Harper BT, Wallis CJD, Klaassen Z.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S747-S750. doi: 10.21037/tau.2018.08.17. No abstract available.

14.

Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis.

Wallis CJD, Butaney M, Satkunasivam R, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z.

JAMA Oncol. 2019 Jan 3. doi: 10.1001/jamaoncol.2018.5904. [Epub ahead of print]

PMID:
30605213
15.

Germ Cell Testicular Tumors-Contemporary Diagnosis, Staging and Management of Localized and Advanced disease.

Goldberg H, Klaassen Z, Chandrasekar T, Fleshner N, Hamilton RJ, Jewett MAS.

Urology. 2019 Mar;125:8-19. doi: 10.1016/j.urology.2018.12.025. Epub 2018 Dec 28. Review.

PMID:
30597167
16.

The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.

Chandrasekar T, Goldberg H, Klaassen Z, Wallis CJD, Woon DTS, Herrera-Caceres JO, Kulkarni GS, Fleshner NE.

Cancer. 2019 Apr 1;125(7):1050-1059. doi: 10.1002/cncr.31916. Epub 2018 Dec 18.

PMID:
30561782
17.

Abiraterone Acetate for Nonmetastatic Castration-Resistant Prostate Cancer-The Forgotten Dance Partner?

Klaassen Z, Wallis CJD, Fleshner NE.

JAMA Oncol. 2018 Nov 29. doi: 10.1001/jamaoncol.2018.5191. [Epub ahead of print] No abstract available.

PMID:
30489621
18.

Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101.

Klaassen Z, Sayyid RK, Wallis CJD.

Eur Urol. 2019 Jan;75(1):85-87. doi: 10.1016/j.eururo.2018.09.035. Epub 2018 Sep 28. No abstract available.

PMID:
30274700
19.

Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study.

Matta R, Wallis CJD, Goldenberg MG, Hird AE, Klaassen Z, Kulkarni G, Kodama RT, Herschorn S, Nam RK.

Eur Urol. 2019 Jan;75(1):3-7. doi: 10.1016/j.eururo.2018.08.035. Epub 2018 Sep 18.

PMID:
30241972
20.

Characterization and outcomes of local treatment for primary bladder lymphoma: A population-based cohort analysis.

Sellman DP, Simpson WG, Klaassen Z, Jen RP, DiBianco JM, Reinstatler L, Li Q, Madi R, Terris MK.

Urol Ann. 2018 Jul-Sep;10(3):249-253. doi: 10.4103/UA.UA_106_17.

Supplemental Content

Loading ...
Support Center